P
PPH
OtherVanEck Pharmaceutical ETF
$100.97
-0.39%
Live · NASDAQ · Mar 28, 6:08 AM
AI InsightNo insight available
What's Moving PPH Today?
No AI insight has been generated for PPH yet. Check back soon — insights are generated from recent news analysis.
Generated Insights
No insights have been generated for PPH yet. Check back soon.
PPH News
20 articles- PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026247 Wall St·Mar 28, 2026
- FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFsYahoo Finance·Mar 23, 2026
- Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookYahoo Finance·Feb 4, 2026
- Should You Invest in the VanEck Pharmaceutical ETF (PPH)?Yahoo Finance·Jan 28, 2026
- VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion247 Wall St·Jan 23, 2026
- Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in ChinaYahoo Finance·Jan 2, 2026
- The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo DrugYahoo Finance·Dec 29, 2025
- Pharma's $370B Bet on America: The ETF Plays for 2026Yahoo Finance·Dec 19, 2025
- Pharma ETFs to Gain From Landmark UK-US Zero-Tariff DealYahoo Finance·Dec 9, 2025
- Looking at the Narrative for Pepkor Holdings After Analyst Upgrades and Renewed OptimismYahoo Finance·Nov 28, 2025
- Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest inYahoo Finance·Nov 24, 2025
- Pharma ETFs in Spotlight Following Robust Q3 Earnings ResultsYahoo Finance·Nov 14, 2025
- Why The Narrative Around Pepkor Holdings Is Shifting After Recent Analyst Upgrades and Outlook ChangesYahoo Finance·Nov 13, 2025
- Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs?Yahoo Finance·Nov 10, 2025
- Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy?Yahoo Finance·Oct 16, 2025
- 4 Reasons to Buy Pharma ETFs Now for a Healthy PortfolioYahoo Finance·Oct 6, 2025
- Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals TariffYahoo Finance·Sep 26, 2025
- Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a HitYahoo Finance·Sep 26, 2025
- NVO Wins FDA Approval for MASH Treatment: ETFs Likely to GainYahoo Finance·Aug 19, 2025
- Cencora Stock: Analyst Estimates & RatingsBarchart·Aug 13, 2025
All 20 articles loaded
Price Data
Open$0.00
Previous Close$100.97
Day High$0.00
Day Low$0.00
52 Week High$112.58
52 Week Low$77.67
52-Week Range
$77.67$112.58
$100.97
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield1.23%
Dividend / Share$1.24
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)467K
Shares Outstanding12.5M
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) · Other
Listed December 20, 2011
Company Details
Security TypeETF
ExchangeNASDAQ
CurrencyUSD
Round Lot100
SIC—
CIK0001137360
Composite FIGIBBG000BCKT22
Share Class FIGIBBG001S73GG5